In breast cancer, down-regulation of Mel-18 enhanced breast CSC self-renewal ability through up-regulating Jagged-1, which was a target of WNT/TCF pathway, and a ligand and activator of Notch pathway [7]. Here, JAG1 is linked to breast carcinoma.